KemPharm signs licensing, debt exchange agreements
KemPharm, a specialty pharmaceutical company based in Coralville, entered a new licensing agreement with an affiliate of Gurnet Point Capital (GPC), a private investment firm focused on the life sciences and medtech sectors, reports the Corridor Business Journal. The agreement provides GPC’s affiliate with an exclusive worldwide license to develop, manufacture…